During the past decade, IPEC - Instituto de Pesquisa Clínica conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "IPEC - Instituto de Pesquisa Clínica" are "Diabetes Mellitus" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Gastroparesis" (2 trials), "Type 2 Diabetes" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "IPEC - Instituto de Pesquisa Clínica" in a lesser frequency.

Most popular intervention types in "IPEC - Instituto de Pesquisa Clínica" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Relamorelin" (2 trials), "Tirzepatide" (2 trials), "Canagliflozin 100 mg" (1 trials) and "Canagliflozin 300 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "IPEC - Instituto de Pesquisa Clínica" are 6 trials for "All" genders.

Currently, there are NaN active trials in "IPEC - Instituto de Pesquisa Clínica". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in IPEC - Instituto de Pesquisa Clínica, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in IPEC - Instituto de Pesquisa Clínica, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".